Document is current
Any future updates will be listed below
-
Authors
Ghadban, Cristina
García-Unzueta, Mayte
Agüero, Juan
Martín-Audera, Paula
Lavín, Bernardo Alio
Guerra, Armando Raúl
Berja, Ana
Aranda, Nieves
Guzun, Anastasia
Insua, Ana Isabel
Amado, Carlos Antonio https://orcid.org/0000-0002-5598-1753
-
Funding
Funding for this research was provided by:
AstraZeneca España
Universidad de Cantabria
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 4 June 2025
First Online: 21 June 2025
Declarations
:
: Carlos Amado has received speaker or consulting fees from Boehringer Ingelheim, Pfizer, Astra-Zeneca, Novartis, Chiesi, Faes Farma, Esteve, GSK, and Bial. The rest of the authors do not have any conflict of interest.
: This study complies with internationally accepted standards for research practice and reporting. The Ethics Committee of our Institution approved the study (2023.297).
: Not applicable.
